# Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain

> **NCT05091047** · NA · COMPLETED · sponsor: **Erchonia Corporation** · enrollment: 9 (actual)

## Conditions studied

- Neuropathy

## Interventions

- **DEVICE:** Erchonia EVRL

## Key facts

- **NCT ID:** NCT05091047
- **Lead sponsor:** Erchonia Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-16
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05091047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05091047, "Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05091047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*